NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 4989-5001

  Allan, Euan R O ^a,b   Tailor, Pankaj ^a,b   Balce, Dale R ^a,b   Pirzadeh, Payman ^a,b   McKenna, Neil T ^a,b   Renaux, Bernard ^a,b   Warren, Amy L ^a   Jirik, Frank R ^b   Yates, Robin M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN L; CATHEPSIN S; CYSTEINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; BINDING SITE; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE DYSREGULATION; IMMUNOMODULATION; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; OXIDATION REDUCTION REACTION; PHAGOSOME; PRIORITY JOURNAL; PROTEIN HYDROLYSIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CATHEPSIN L; CATHEPSINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NADPH OXIDASE; OXIDATION-REDUCTION;

EID: 84901257403     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302896     Document Type: Article

References (73)

1. Delamarre, L., M. Pack, H. Chang, I. Mellman, and E. S. Trombetta. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307: 1630-1634.
2. Delamarre, L., R. Couture, I. Mellman, and E. S. Trombetta. 2006. Enhancing immunogenicity by limiting susceptibility to lysosomal proteolysis. J. Exp. Med. 203: 2049-2055.
3. Savina, A., C. Jancic, S. Hugues, P. Guermonprez, P. Vargas, I. C. Moura, A. M. Lennon-Duménil, M. C. Seabra, G. Raposo, and S. Amigorena. 2006. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218.
4. Balce, D. R., B. Li, E. R. Allan, J. M. Rybicka, R. M. Krohn, and R. M. Yates. 2011. Alternative activation of macrophages by IL-4 enhances the proteolytic capacity of their phagosomes through synergistic mechanisms. Blood 118: 4199-4208.
5. Rybicka, J. M., D. R. Balce, M. F. Khan, R. M. Krohn, and R. M. Yates. 2010. NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes. Proc. Natl. Acad. Sci. USA 107: 10496-10501.
6. Mantegazza, A. R., A. Savina, M. Vermeulen, L. Pérez, J. Geffner, O. Hermine, S. D. Rosenzweig, F. Faure, and S. Amigorena. 2008. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112: 4712-4722.
7. Rybicka, J. M., D. R. Balce, S. Chaudhuri, E. R. Allan, and R. M. Yates. 2012. Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner. EMBO J. 31: 932-944.
8. Collins, D. S., E. R. Unanue, and C. V. Harding. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147: 4054-4059.
9. Hastings, K. T., R. L. Lackman, and P. Cresswell. 2006. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J. Immunol. 177: 8569-8577.
10. Stromnes, I. M., and J. M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810-1819.
11. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
12. Nakahara, J., S. Aiso, and N. Suzuki. 2010. Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis. Arch. Immunol. Ther. Exp. (Warsz.) 58: 325-333.
13. Chastain, E. M., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
14. Almolda, B., B. Gonzalez, and B. Castellano. 2011. Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci (Landmark Ed) 16: 1157-1171.
15. Lodygin, D., F. Odoardi, C. Schläger, H. Körner, A. Kitz, M. Nosov, J. van den Brandt, H. M. Reichardt, M. Haberl, and A. Flugel. 2013. A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity. Nat. Med. 19: 784-790.
16. Zal, T., A. Volkmann, and B. Stockinger. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180: 2089-2099.
17. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18: 97-104.
18. van der Veen, R. C., T. A. Dietlin, F. M. Hofman, L. Pen, B. H. Segal, and S. M. Holland. 2000. Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J. Immunol. 164: 5177-5183.
19. Agrawal, S. M., C. Silva, W. W. Tourtellotte, and V. W. Yong. 2011. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. 31: 669-677.
20. VanderVen, B. C., R. M. Yates, and D. G. Russell. 2009. Intraphagosomal measurement of the magnitude and duration of the oxidative burst. Traffic 10: 372-378.
21. Yates, R. M., A. Hermetter, and D. G. Russell. 2005. The kinetics of phagosome maturation as a function of phagosome/lysosome fusion and acquisition of hydrolytic activity. Traffic 6: 413-420.
22. Russell, D. G., and R. M. Yates. 2007. TLR signalling and phagosome maturation: an alternative viewpoint. Cell. Microbiol. 9: 849-850.
23. Yates, R. M., and D. G. Russell. 2008. Real-time spectrofluorometric assays for the lumenal environment of the maturing phagosome. Methods Mol. Biol. 445: 311-325.
24. Yates, R. M., A. Hermetter, and D. G. Russell. 2009. Recording phagosome maturation through the real-time, spectrofluorometric measurement of hydrolytic activities. Methods Mol. Biol. 531: 157-171.
25. Underhill, D. M., M. Bassetti, A. Rudensky, and A. Aderem. 1999. Dynamic interactions of macrophages with T cells during antigen presentation. J. Exp. Med. 190: 1909-1914.
26. Alfonso, C., G. S. Williams, J. O. Han, J. A. Westberg, O. Winqvist, and L. Karlsson. 2003. Analysis of H2-O influence on antigen presentation by B cells. J. Immunol. 171: 2331-2337.
27. Shastri, N., A. Miller, and E. E. Sercarz. 1984. The expressed T cell repertoire is hierarchical: the precise focus of lysozyme-specific T cell clones is dependent upon the structure of the immunogen. J. Mol. Cell. Immunol. 1: 369-379.
28. Alfonso, C., J. O. Han, G. S. Williams, and L. Karlsson. 2001. The impact of H2- DM on humoral immune responses. J. Immunol. 167: 6348-6355.
29. Norton, W. T., and S. E. Poduslo. 1973. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21: 749-757.
30. Ciabattini, A., E. Pettini, P. Andersen, G. Pozzi, and D. Medaglini. 2008. Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria. Infect. Immun. 76: 5817-5825.
31. Hori, S., T. Takahashi, and S. Sakaguchi. 2003. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81: 331-371.
32. Atif, S. M., S. Uematsu, S. Akira, and S. J. McSorley. 2014. CD1032CD11b+ dendritic cells regulate the sensitivity of CD4 T-cell responses to bacterial flagellin. Mucosal Immunol. 7: 68-77.
33. Wood, K. J., H. Ushigome, M. Karim, A. Bushell, S. Hori, and S. Sakaguchi. 2003. Regulatory cells in transplantation. Novartis Found. Symp. 252: 177-188.
34. Krishnamoorthy, G., A. Saxena, L. T. Mars, H. S. Domingues, R. Mentele, A. Ben-Nun, H. Lassmann, K. Dornmair, F. C. Kurschus, R. S. Liblau, and H. Wekerle. 2009. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat. Med. 15: 626-632.
35. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
36. Lal, J., and M. Smriti. 2008. Should drug-pre-filled syringes be made available with disposable spinal needles? Acta Anaesthesiol. Scand. 52: 1175-1176.
37. Choi, S. H., D. Y. Lee, E. S. Chung, Y. B. Hong, S. U. Kim, and B. K. Jin. 2005. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J. Neurochem. 95: 1755-1765.
38. Williams, J. L., A. P. Kithcart, K. M. Smith, T. Shawler, G. M. Cox, and C. C. Whitacre. 2011. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 234: 84-92.
39. Yang, K., J. L. Vega, M. Hadzipasic, J. P. Schatzmann Peron, B. Zhu, Y. Carrier, S. Masli, L. V. Rizzo, and H. L. Weiner. 2009. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. J. Autoimmun. 32: 94-103.
40. Racke, M. K., D. Burnett, S. H. Pak, P. S. Albert, B. Cannella, C. S. Raine, D. E. McFarlin, and D. E. Scott. 1995. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J. Immunol. 154: 450-458.
41. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84: 543-550.
42. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
43. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J. A. Villadangos, H. Ploegh, C. Peters, and A. Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450-453.
44. Mintseris, J., B. Pierce, K. Wiehe, R. Anderson, R. Chen, and Z. Weng. 2007. Integrating statistical pair potentials into protein complex prediction. Proteins 69: 511-520.
45. Mellman, I., S. J. Turley, and R. M. Steinman. 1998. Antigen processing for amateurs and professionals. Trends Cell Biol. 8: 231-237.
46. Pethe, K., D. L. Swenson, S. Alonso, J. Anderson, C. Wang, and D. G. Russell. 2004. Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl. Acad. Sci. USA 101: 13642-13647.
47. Pillay, C. S., E. Elliott, and C. Dennison. 2002. Endolysosomal proteolysis and its regulation. Biochem. J. 363: 417-429.
48. Nelson, P. A., M. Khodadoust, T. Prodhomme, C. Spencer, J. C. Patarroyo, M. Varrin-Doyer, J. D. Ho, R. M. Stroud, and S. S. Zamvil. 2010. Immunodominant T cell determinants of aquaporin-4, the autoantigen associated with neuromyelitis optica. PLoS ONE 5: e15050.
49. Verspurten, J., K. Gevaert, W. Declercq, and P. Vandenabeele. 2009. SitePredicting the cleavage of proteinase substrates. Trends Biochem. Sci. 34: 319-323.
50. Carrillo-Vico, A., M. D. Leech, and S. M. Anderton. 2010. Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system. J. Immunol. 184: 2839-2846.
51. Yan, Y., H. Laroui, S. A. Ingersoll, S. Ayyadurai, M. Charania, S. Yang, G. Dalmasso, T. S. Obertone, H. Nguyen, S. V. Sitaraman, and D. Merlin. 2011. Overexpression of Ste20-related proline/alanine-rich kinase exacerbates experimental colitis in mice. J. Immunol. 187: 1496-1505.
52. Través, P. G., R. López-Fontal, A. Luque, and S. Hortelano. 2011. The tumor suppressor ARF regulates innate immune responses in mice. J. Immunol. 187: 6527-6538.
53. Anderson, A. C., R. Chandwaskar, D. H. Lee, J. M. Sullivan, A. Solomon, R. Rodriguez-Manzanet, B. Greve, R. A. Sobel, and V. K. Kuchroo. 2012. A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J. Immunol. 188: 2084-2092.
54. McNeil, L. K., and B. D. Evavold. 2003. TCR reserve: a novel principle of CD4 T cell activation by weak ligands. J. Immunol. 170: 1224-1230.
55. Petersen, T. R., E. Bettelli, J. Sidney, A. Sette, V. Kuchroo, and B. T. Bäckström. 2004. Characterization of MHC- and TCR-binding residues of the myelin oligodendrocyte glycoprotein 38-51 peptide. Eur. J. Immunol. 34: 165-173.
56. Ben-Nun, A., N. Kerlero de Rosbo, N. Kaushansky, M. Eisenstein, L. Cohen, J. F. Kaye, and I. Mendel. 2006. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice. Eur. J. Immunol. 36: 478-493.
57. Beers, C., K. Honey, S. Fink, K. Forbush, and A. Rudensky. 2003. Differential regulation of cathepsin S and cathepsin L in interferon g-treated macrophages. J. Exp. Med. 197: 169-179.
58. Honey, K., M. Duff, C. Beers, W. H. Brissette, E. A. Elliott, C. Peters, M. Maric, P. Cresswell, and A. Rudensky. 2001. Cathepsin S regulates the expression of cathepsin L and the turnover of g-interferon-inducible lysosomal thiol reductase in B lymphocytes. J. Biol. Chem. 276: 22573-22578.
59. Hsing, L. C., and A. Y. Rudensky. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207: 229-241.
60. Lanzavecchia, A., and F. Sallusto. 2001. Regulation of T cell immunity by dendritic cells. Cell 106: 263-266.
61. Yi, L., Q. Liu, M. S. Orandle, S. Sadiq-Ali, S. M. Koontz, U. Choi, F. J. Torres-Velez, and S. H. Jackson. 2012. p47phox directs murine macrophage cell fate decisions. Am. J. Pathol. 180: 1049-1058.
62. Choi, S. H., S. Aid, H. W. Kim, S. H. Jackson, and F. Bosetti. 2012. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J. Neurochem. 120: 292-301.
63. Hultqvist, M., P. Olofsson, J. Holmberg, B. T. Bäckström, J. Tordsson, and R. Holmdahl. 2004. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. USA 101: 12646-12651.
64. von Budingen, H. C., N. Tanuma, P. Villoslada, J. C. Ouallet, S. L. Hauser, and C. P. Genain. 2001. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J. Clin. Immunol. 21: 155-170.
65. Manoury, B., D. Mazzeo, L. Fugger, N. Viner, M. Ponsford, H. Streeter, G. Mazza, D. C. Wraith, and C. Watts. 2002. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP. Nat. Immunol. 3: 169-174.
66. Lennon-Duménil, A. M., A. H. Bakker, R. Maehr, E. Fiebiger, H. S. Overkleeft, M. Rosemblatt, H. L. Ploegh, and C. Lagaudrière-Gesbert. 2002. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196: 529-540.
67. Jacob, C. O., M. Eisenstein, M. C. Dinauer, W. Ming, Q. Liu, S. John, F. P. Quismorio, Jr., A. Reiff, B. L. Myones, K. M. Kaufman, et al. 2012. Lupusassociated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc. Natl. Acad. Sci. USA 109: E59-E67.
68. De Ravin, S. S., N. Naumann, E. W. Cowen, J. Friend, D. Hilligoss, M. Marquesen, J. E. Balow, K. S. Barron, M. L. Turner, J. I. Gallin, and H. L. Malech. 2008. Chronic granulomatous disease as a risk factor for autoimmune disease. J. Allergy Clin. Immunol. 122: 1097-1103.
69. Lee, B. W., and H. K. Yap. 1994. Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous disease. Arthritis Rheum. 37: 773-776.
70. Matute, J. D., A. A. Arias, N. A. Wright, I. Wrobel, C. C. Waterhouse, X. J. Li, C. C. Marchal, N. D. Stull, D. B. Lewis, M. Steele, et al. 2009. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40phox and selective defects in neutrophil NADPH oxidase activity. Blood 114: 3309-3315.
71. Olsson, L. M., A. K. Lindqvist, H. Källberg, L. Padyukov, H. Burkhardt, L. Alfredsson, L. Klareskog, and R. Holmdahl. 2007. A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res. Ther. 9: R98.
72. Rioux, J. D., R. J. Xavier, K. D. Taylor, M. S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M. M. Barmada, L. W. Datta, et al. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39: 596-604.
73. Gardiner, G. J., S. N. Deffit, S. McLetchie, L. Pérez, C. C. Walline, and J. S. Blum. 2013. A role for NADPH oxidase in antigen presentation. Front. Immunol. 4: 295.